Colorectal Cancer Risk Higher for Patients With a Prostate Cancer Diagnosis

The risk for developing colorectal cancer is increased after a diagnosis of prostate cancer.
The risk for developing colorectal cancer is increased after a diagnosis of prostate cancer.

The risk for developing colorectal cancer is increased after a diagnosis of prostate cancer, a study published in the journal Cancer has shown.1

Because there are limited data on the risk of colorectal cancer among prostate cancer survivors, researchers sought to conduct a rigorous assessment of the risk after controlling for confounding factors and competing risks.

For the study, researchers analyzed data from 14 164 men with prostate cancer diagnosed between 1987 and 2009 and 69 051 men without prostate cancer from Manitoba, Canada. Patients were followed to the date of diagnosis of another cancer, death, emigration, or when the study ended at the end of 2009.

Continue Reading Below

Results showed that men with prostate cancer had an elevated risk for subsequent development of colorectal cancer (HR, 1.14; 95% CI: 1.02-1.27). Researchers found that the risk was highest for rectal cancer (HR, 1.36; 95% CI: 1.09-1.71).

The study also demonstrated that treating prostate cancer with radiation was associated with an increased risk for rectal cancer compared with those whose prostate cancer was not treated with radiation (HR, 2.06; 95% CI: 1.42-2.99).

The findings suggest that colorectal cancer screening should be considered following a diagnosis of prostate cancer, particularly for patients considering radiotherapy.

REFERENCE

1. Desautels D, Czaykowski P, Nugent Z, et al. Risk of colorectal cancer after the diagnosis of prostate cancer: a population-based study [published online ahead of print February 25, 2016]. Cancer. doi:10.1002/cncr.29919.

Continue Reading Below

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs